JP2004526721A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526721A5
JP2004526721A5 JP2002569834A JP2002569834A JP2004526721A5 JP 2004526721 A5 JP2004526721 A5 JP 2004526721A5 JP 2002569834 A JP2002569834 A JP 2002569834A JP 2002569834 A JP2002569834 A JP 2002569834A JP 2004526721 A5 JP2004526721 A5 JP 2004526721A5
Authority
JP
Japan
Prior art keywords
group
compound
compound according
optionally substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2002569834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526721A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/001942 external-priority patent/WO2002070514A1/en
Publication of JP2004526721A publication Critical patent/JP2004526721A/ja
Publication of JP2004526721A5 publication Critical patent/JP2004526721A5/ja
Ceased legal-status Critical Current

Links

JP2002569834A 2001-03-02 2002-02-25 Ipアンタゴニストとしてのアルコキシカルボニルアミノヘテロアリールカルボン酸誘導体 Ceased JP2004526721A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27284901P 2001-03-02 2001-03-02
PCT/EP2002/001942 WO2002070514A1 (en) 2001-03-02 2002-02-25 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists

Publications (2)

Publication Number Publication Date
JP2004526721A JP2004526721A (ja) 2004-09-02
JP2004526721A5 true JP2004526721A5 (cg-RX-API-DMAC7.html) 2005-06-30

Family

ID=23041569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002569834A Ceased JP2004526721A (ja) 2001-03-02 2002-02-25 Ipアンタゴニストとしてのアルコキシカルボニルアミノヘテロアリールカルボン酸誘導体

Country Status (14)

Country Link
US (1) US6569860B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368345B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004526721A (cg-RX-API-DMAC7.html)
KR (1) KR100589990B1 (cg-RX-API-DMAC7.html)
CN (1) CN1280289C (cg-RX-API-DMAC7.html)
AR (1) AR033429A1 (cg-RX-API-DMAC7.html)
AT (1) ATE321041T1 (cg-RX-API-DMAC7.html)
BR (1) BR0207730A (cg-RX-API-DMAC7.html)
CA (1) CA2438813C (cg-RX-API-DMAC7.html)
DE (1) DE60210058T2 (cg-RX-API-DMAC7.html)
ES (1) ES2260425T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007864A (cg-RX-API-DMAC7.html)
WO (1) WO2002070514A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200306283B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
WO2004071508A1 (en) * 2003-02-14 2004-08-26 Medical Research Council Ip receptor antagonists for the treatment of pathological uterine conditions
US7262313B2 (en) * 2005-10-20 2007-08-28 Lg Chem, Ltd. Organic silane compound
KR100840114B1 (ko) * 2005-10-20 2008-06-19 주식회사 엘지화학 점착제 조성물
AR069650A1 (es) * 2007-12-14 2010-02-10 Actelion Pharmaceuticals Ltd Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
WO2014143591A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors
WO2014143592A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid ip receptors
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
EP4119138A1 (en) * 2021-07-12 2023-01-18 Universität Hamburg Dhodh inhibitors and their use as antiviral agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908842A (en) 1995-12-08 1999-06-01 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
WO1999026925A1 (en) * 1997-11-26 1999-06-03 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitors comprising heterocyclic amide compounds
BR9914091A (pt) * 1998-10-06 2001-11-27 Dainippon Pharmaceutical Co Derivados de piridina 2,3-di-substituìda, processopara preparação dos mesmos, composições dedroga contendo os mesmos e intermediários paraa preparação
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
MXPA02001498A (es) * 1999-08-12 2003-07-21 Pharmacia & Italia S P A Derivados de 3(5)-amino-pirazol, procedimiento para la preparacion de los mismos y usos como agentes antitumorales.
JP3938689B2 (ja) 2000-03-16 2007-06-27 エフ.ホフマン−ラ ロシュ アーゲー Ipアンタゴニストとしてのカルボン酸誘導体

Similar Documents

Publication Publication Date Title
JP2008513515A5 (cg-RX-API-DMAC7.html)
JP2005508967A5 (cg-RX-API-DMAC7.html)
JP2008513516A5 (cg-RX-API-DMAC7.html)
JP2008513498A5 (cg-RX-API-DMAC7.html)
JP2005508923A5 (cg-RX-API-DMAC7.html)
JP2007520440A5 (cg-RX-API-DMAC7.html)
JP2007519649A5 (cg-RX-API-DMAC7.html)
JP2009537559A5 (cg-RX-API-DMAC7.html)
JP2005511698A5 (cg-RX-API-DMAC7.html)
JP2005526696A5 (cg-RX-API-DMAC7.html)
JP2017538689A5 (cg-RX-API-DMAC7.html)
JP2007507494A5 (cg-RX-API-DMAC7.html)
RU2010127297A (ru) 5-галогензамещенные производные оксиндола и их применение для лечения вазопрессинзависимых заболеваний
JP2004507527A5 (cg-RX-API-DMAC7.html)
JP2004529145A5 (cg-RX-API-DMAC7.html)
WO2006125180B1 (en) Piperazine derivatives and their uses as therapeutic agents
JP2020534266A5 (cg-RX-API-DMAC7.html)
JP2009501745A5 (cg-RX-API-DMAC7.html)
RU2004129285A (ru) Производные тиазола в качестве антагонистов рецептора npy
JP2004525183A5 (cg-RX-API-DMAC7.html)
JP2007521312A5 (cg-RX-API-DMAC7.html)
JP2005538974A5 (cg-RX-API-DMAC7.html)
JP2014504648A5 (cg-RX-API-DMAC7.html)
JP2005502636A5 (cg-RX-API-DMAC7.html)
JP2005506151A5 (cg-RX-API-DMAC7.html)